Reliv' International, Inc. (RELV) |
| 2.071 -0.071 (-3.43%) 04-13 09:30 |
| Open: | 2.071 |
| High: | 2.071 |
| Low: | 2.071 |
| Volume: | 37 |
| Market Cap: | 4(M) |
| PE Ratio: | -41.42 |
| Exchange: | Other OTC |
| Industry: | Packaged Foods |
| Sector: | Consumer Defensive |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 377.04 |
| Resistance 1: | 322.81 |
| Pivot price: | 302.29 |
| Support 1: | 295.91 |
| Support 2: | 279.28 |
| 52w High: | 3.18 |
| 52w Low: | 1.7 |
Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.
| EPS | 25.200 |
| Book Value | 198.810 |
| PEG Ratio | 0.00 |
| Gross Profit | 230.630 |
| Profit Margin (%) | 2.84 |
| Operating Margin (%) | 1.54 |
| Return on Assets (ttm) | 4.3 |
| Return on Equity (ttm) | 13.3 |
Mon, 06 Sep 2021
What date does 's (RELV) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research
Thu, 24 Dec 2020
RELV Stock Price and Chart — OTC:RELV - TradingView — Track All Markets
Fri, 04 Dec 2020
Reliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common Stock - PR Newswire
Wed, 02 Dec 2020
Reliv Stock Price Forecast. Should You Buy RELV? - StockInvest.us
Wed, 07 Aug 2019
Dr. Alfredo Galvez Appointed as Reliv International’s Chief Scientific Advisor - BioSpace
Mon, 01 Apr 2019
Reliv Sales Down Nearly 14% for 2018 - directsellingnews.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |